- Companies
- 874
- Combined market cap
- $8.4T
- Median PE
- 26.7×
- Median revenue growth
- +8.4%
- Median net margin
- −0.5%
| Company | Market cap | PE | P/S | Revenue growth | Net margin | Dividend yield |
|---|
LLYEli Lilly and, Drug Manufacturers - Generalcaveat | $1.3T | 46.5× | 15.6× | +46% | 31.9% | 0.47% |
|---|
JNJJohnson & Johnson, Drug Manufacturers - Generalcaveat | $650.2B | 40.9× | 6.5× | +8% | n/m | 1.96% |
|---|
ABBVAbbVie, Drug Manufacturers - Generalcaveat | $511.6B | 49.8× | 7.7× | +11% | 15.7% | 2.39% |
|---|
MRKMerck, Drug Manufacturers - Generalcaveat | $359.5B | 150× | 5.3× | +5% | 3.6% | 2.33% |
|---|
UNHUnitedHealth, Medical - Healthcare Planscaveat | $356.9B | 22.7× | 0.8× | +3% | 3.5% | 2.28% |
|---|
TMOThermo Fisher Scientific, Medical - Diagnostics & Researchcaveat | $256.9B | 36.7× | 5.4× | +8% | 14.9% | 0.26% |
|---|
AMGNAmgen, Drug Manufacturers - General | $252.3B | 29.0× | 6.6× | +9% | 23.0% | 2.13% |
|---|
GILDGilead Sciences, Drug Manufacturers - Generalcaveat | $212.5B | n/m | 6.9× | +7% | −12.5% | 1.90% |
|---|
ABTAbbott Laboratories, Medical - Devicescaveat | $190.6B | 41.1× | n/m | n/m | n/m | 2.29% |
|---|
PFEPfizer, Drug Manufacturers - General | $176B | 40.6× | 2.8× | −0% | 6.8% | 5.57% |
|---|
DHRDanaher, Medical - Diagnostics & Researchcaveat | $162.6B | 37.9× | 6.3× | +6% | 16.9% | 0.66% |
|---|
ISRGIntuitive Surgical, Medical - Instruments & Suppliescaveat | $154.6B | 52.9× | 13.4× | +20% | 25.5% | n/m |
|---|
VRTXVertex Pharmaceuticals, Biotechnologycaveat | $137.1B | 31.5× | 10.9× | +10% | 35.0% | n/m |
|---|
BMYBristol-Myers Squibb, Drug Manufacturers - Generalcaveat | $128.7B | 14.0× | 2.6× | +4% | 18.5% | 4.00% |
|---|
MDTMedtronic, Medical - Devices | $126.7B | 24.3× | 3.4× | +10% | 13.9% | 2.89% |
|---|
SYKStryker, Medical - Devices | $118.6B | 32.1× | 4.6× | +8% | 14.4% | 1.14% |
|---|
MCKMcKesson, Medical - Distribution | $116.5B | 26.8× | 0.3× | +9% | 1.1% | 0.34% |
|---|
CVSCVS Health, Medical - Healthcare Plans | $113.7B | 23.5× | 0.3× | +7% | 1.2% | 2.99% |
|---|
HCAHCA Healthcare, Medical - Care Facilities | $100.9B | 15.6× | 1.3× | +7% | 8.8% | 0.66% |
|---|
REGNRegeneron Pharmaceuticals, Biotechnology | $100B | 24.0× | 6.4× | +9% | 27.9% | 0.38% |
|---|
MRNAModerna, Biotechnology | $92.1B | n/m | 41.3× | −28% | n/m | n/m |
|---|
ELVElevance Health, Medical - Healthcare Plans | $89.7B | 18.4× | 0.4× | +6% | 2.5% | 1.66% |
|---|
CICigna, Medical - Healthcare Plans | $77.8B | 12.2× | 0.3× | +8% | 2.3% | 2.10% |
|---|
CORCencora, Medical - Distribution | $64.4B | 25.1× | 0.2× | +5% | 0.8% | 0.71% |
|---|
BSXBoston Scientific, Medical - Devices | $63B | 17.6× | 3.0× | +14% | 17.5% | n/m |
|---|
CAHCardinal Health, Medical - Distribution | $59.2B | 35.2× | 0.2× | +14% | 0.7% | 0.81% |
|---|
NTRANatera, Medical - Diagnostics & Research | $56.2B | n/m | 20.7× | +38% | −7.1% | n/m |
|---|
EWEdwards Lifesciences, Medical - Devices | $54.6B | 54.5× | 8.4× | +15% | 15.4% | n/m |
|---|
BDXBecton, Dickinson and, Medical - Instruments & Supplies | $54B | 59.9× | 2.6× | +5% | 4.5% | 2.00% |
|---|
IDXXIDEXX Laboratories, Medical - Diagnostics & Research | $52.1B | 46.5× | 11.4× | +13% | 25.0% | n/m |
|---|
TEVATeva Pharmaceutical Industries, Drug Manufacturers - Specialty & Generic | $49.7B | 71.1× | 2.9× | +4% | 4.1% | n/m |
|---|
AAgilent Technologies, Medical - Diagnostics & Research | $49.6B | 34.5× | 6.7× | +9% | 19.5% | 0.58% |
|---|
HUMHumana, Medical - Healthcare Plans | $49.5B | 39.0× | 0.3× | +18% | 0.9% | 0.86% |
|---|
WATWaters, Medical - Diagnostics & Research | $46.4B | 118× | 10.0× | +52% | 3.6% | n/m |
|---|
MDLNMedline, Medical - Instruments & Suppliescaveat | $43.8B | n/m | n/m | n/m | n/m | n/m |
|---|
IQVIQVIA, Medical - Diagnostics & Research | $42.5B | 32.0× | 2.5× | +8% | 8.1% | n/m |
|---|
RVMDRevolution Medicines, Biotechnology | $41.7B | n/m | n/m | n/m | n/m | n/m |
|---|
ONCBeOne Medicines, Biotechnology | $40.2B | 63.2× | 6.6× | +34% | 10.7% | n/m |
|---|
RPRXRoyalty Pharma, Medical - Pharmaceuticals | $38.7B | 38.2× | 15.3× | +10% | 32.1% | 1.37% |
|---|
BIIBBiogen, Drug Manufacturers - General | $37B | 44.3× | 3.7× | +0% | 8.3% | n/m |
|---|
GEHCGE HealthCare Technologies, Medical - Devices | $36B | 18.3× | 1.7× | +7% | 9.3% | 0.18% |
|---|
ILMNIllumina, Medical - Diagnostics & Research | $35.7B | 44.0× | 8.0× | +5% | 18.4% | n/m |
|---|
ZTSZoetis, Drug Manufacturers - Specialty & Generic | $34.3B | 13.7× | 3.6× | +1% | 27.5% | 2.52% |
|---|
MTDMettler-Toledo International, Medical - Diagnostics & Research | $34.2B | 38.4× | 8.3× | +7% | 21.9% | n/m |
|---|
CNCCentene, Medical - Healthcare Plans | $32.8B | n/m | 0.2× | +14% | −2.5% | n/m |
|---|
RMDResMed, Medical - Instruments & Supplies | $32.3B | 21.4× | 5.7× | +10% | 26.9% | 1.10% |
|---|
DXCMDexCom, Medical - Devices | $31.9B | 33.6× | 6.4× | +16% | 20.1% | n/m |
|---|
WSTWest Pharmaceutical Services, Medical - Instruments & Supplies | $28.9B | 52.5× | 8.7× | +12% | 17.0% | 0.21% |
|---|
LHLabcorp, Medical - Diagnostics & Research | $28.9B | 29.4× | 2.0× | +6% | 7.0% | 0.81% |
|---|
DGXQuest Diagnostics, Medical - Diagnostics & Research | $27.5B | 24.9× | 2.3× | +9% | 9.5% | 1.35% |
|---|
ROIVRoivant Sciences, Biotechnology | $26.2B | n/m | n/m | −68% | n/m | n/m |
|---|
UTHRUnited Therapeutics, Biotechnology | $25.9B | 21.6× | 8.2× | +2% | 41.6% | n/m |
|---|
INCYIncyte, Biotechnology | $24.3B | 15.3× | 4.2× | +27% | 27.7% | n/m |
|---|
INSMInsmed, Biotechnology | $23.7B | n/m | 20.8× | +186% | −76.9% | n/m |
|---|
GHGuardant Health, Medical - Diagnostics & Research | $23.7B | n/m | 20.0× | +43% | −38.3% | n/m |
|---|
STESTERIS, Medical - Specialties | $22.7B | 28.4× | 3.8× | +8% | 13.3% | 1.11% |
|---|
THCTenet Healthcare, Medical - Care Facilities | $21.5B | 10.3× | 1.0× | +5% | 10.3% | n/m |
|---|
VTRSViatris, Drug Manufacturers - Specialty & Genericcaveat | $21.4B | n/m | 1.5× | +4% | −2.8% | n/m |
|---|
ALNYAlnylam Pharmaceuticals, Biotechnology | $21.2B | 26.7× | 4.4× | +95% | 16.8% | n/m |
|---|
ZBHZimmer Biomet, Medical - Devices | $18.6B | 23.7× | 2.2× | +9% | 9.5% | n/m |
|---|
MEDPMedpace, Medical - Diagnostics & Research | $18.1B | 38.0× | 6.5× | +25% | 17.7% | n/m |
|---|
EXELExelixis, Biotechnology | $17.4B | 22.1× | 7.1× | +9% | 35.3% | n/m |
|---|
RVTYRevvity, Medical - Diagnostics & Research | $16.9B | 72.2× | 5.8× | +4% | 8.2% | n/m |
|---|
CRLCharles River Laboratories International, Medical - Diagnostics & Research | $16.2B | n/m | 4.0× | −1% | −6.0% | n/m |
|---|
NBIXNeurocrine Biosciences, Biotechnology | $14.8B | 21.3× | 4.4× | +34% | 20.9% | n/m |
|---|
BBIOBridgeBio Pharma, Drug Manufacturers - General | $14.7B | n/m | 20.6× | +202% | −97.0% | n/m |
|---|
HALOHalozyme Therapeutics, Biotechnology | $14.6B | 38.5× | 8.8× | +41% | 24.9% | n/m |
|---|
SOLVSolventum, Medical - Instruments & Supplies | $14.4B | 10.4× | 1.7× | −1% | 17.3% | n/m |
|---|
GKOSGLAUKOS, Medical - Instruments & Supplies | $14.1B | n/m | 23.0× | +42% | −30.7% | n/m |
|---|
JAZZJazz Pharmaceuticals, Drug Manufacturers - General | $13.9B | 14.7× | 3.0× | +13% | 20.4% | n/m |
|---|
EHCEncompass Health, Medical - Care Facilities | $13.5B | 22.3× | 2.2× | +9% | 10.0% | n/m |
|---|
BTSGBrightSpring Health Services, Medical - Care Facilities | $13.1B | 40.2× | 0.9× | +26% | 2.5% | n/m |
|---|
PENPenumbra, Medical - Instruments & Supplies | $12.7B | 79.0× | 8.4× | +18% | 10.7% | n/m |
|---|
BAXBaxter International, Medical - Instruments & Supplies | $12.5B | n/m | 1.1× | +5% | −9.3% | n/m |
|---|
ELANElanco Animal Health, Drug Manufacturers - General | $12B | n/m | 2.4× | +12% | −4.0% | n/m |
|---|
DVADavita, Medical - Care Facilities | $11.9B | 15.2× | 0.8× | +6% | 6.0% | n/m |
|---|
SMMTSummit Therapeutics, Drug Manufacturers - General | $11.8B | n/m | n/m | n/m | n/m | n/m |
|---|
COOCooper Companies, Medical - Instruments & Supplies | $11.7B | 20.9× | 2.8× | +5% | 13.5% | n/m |
|---|
TECHBIO-TECHNE, Biotechnology | $11.4B | 63.2× | 9.4× | −0% | 15.0% | n/m |
|---|
BMRNBiomarin Pharmaceutical, Drug Manufacturers - General | $11.1B | 155× | 3.3× | +11% | 2.1% | n/m |
|---|
ALGNAlign Technology, Medical - Instruments & Supplies | $10.9B | 26.8× | 2.6× | +4% | 10.0% | n/m |
|---|
MOHMolina Healthcare, Medical - Healthcare Plans | $10.9B | n/m | 0.2× | +3% | −0.0% | n/m |
|---|
GMEDGlobus Medical, Medical - Instruments & Supplies | $10.7B | 20.3× | 3.4× | +20% | 17.0% | n/m |
|---|
PODDInsulet, Medical - Instruments & Supplies | $10.7B | 28.7× | 3.5× | +29% | 12.3% | n/m |
|---|
UHSUniversal Health Services, Medical - Care Facilities | $10.6B | 7.4× | 0.6× | +10% | 8.4% | n/m |
|---|
KYMRKymera Therapeutics, Biotechnology | $10.6B | n/m | 101× | +135% | n/m | n/m |
|---|
AVTRAvantor, Medical - Diagnostics & Research | $10.6B | n/m | 1.6× | −2% | −8.8% | n/m |
|---|
ENSGEnsign, Medical - Care Facilities | $10.4B | 28.1× | 1.9× | +19% | 6.9% | n/m |
|---|
MDGLMadrigal Pharmaceuticals, Drug Manufacturers - General | $10B | n/m | 7.8× | +149% | −25.3% | n/m |
|---|
BIOBio-Rad Laboratories, Medical - Diagnostics & Research | $9.8B | 44.4× | 3.8× | +1% | 8.6% | n/m |
|---|
RGENRepligen, Biotechnology | $9.8B | 237× | 12.4× | +16% | 5.3% | n/m |
|---|
HSICHenry Schein, Medical - Distribution | $9.7B | 25.3× | 0.7× | +6% | 3.0% | n/m |
|---|
OSCROscar Health, Medical - Healthcare Plans | $9.6B | 22.3× | 0.6× | +43% | 3.6% | n/m |
|---|
TGTXTG Therapeutics, Drug Manufacturers - General | $9.2B | 21.9× | 11.5× | +76% | 55.2% | n/m |
|---|
CAICaris Life Sciences, Medical - Diagnostics & Research | $9.1B | 86.8× | 9.2× | +85% | 10.6% | n/m |
|---|
PCVXVaxcyte, Biotechnology | $9B | n/m | n/m | n/m | n/m | n/m |
|---|
PTGXProtagonist Therapeutics, Drug Manufacturers - General | $9B | 135× | 32.0× | +35% | 29.4% | n/m |
|---|
KRYSKrystal Biotech, Biotechnology | $8.8B | 37.1× | 19.9× | +23% | 54.8% | n/m |
|---|
CORTCorcept Therapeutics, Drug Manufacturers - General | $8.7B | 192× | 10.5× | +16% | 6.6% | n/m |
|---|
CYTKCytokinetics, Drug Manufacturers - General | $8.6B | n/m | 127× | −21% | n/m | n/m |
|---|
BRKRBruker, Medical - Diagnostics & Research | $8.5B | n/m | 2.4× | +2% | −2.0% | n/m |
|---|
IBRXImmunityBio, Biotechnology | $8.4B | n/m | 50.8× | +193% | n/m | n/m |
|---|
SYRESpyre Therapeutics, Drug Manufacturers - General | $8.4B | n/m | n/m | n/m | n/m | n/m |
|---|
ARWRArrowhead Pharmaceuticals, Drug Manufacturers - General | $8.4B | n/m | 12.6× | +17% | −47.8% | n/m |
|---|
TWSTTwist Bioscience, Biotechnology | $8.1B | n/m | 18.7× | +19% | −31.7% | n/m |
|---|
TXG10x Genomics, Medical - Diagnostics & Research | $8B | n/m | 13.0× | −4% | −12.2% | n/m |
|---|
PRAXPraxis Precision Medicines, Drug Manufacturers - Generalcaveat | $7.6B | n/m | n/m | n/m | n/m | n/m |
|---|
ALKSAlkermes plc., Drug Manufacturers - General | $7.5B | 118× | 4.5× | +11% | 4.0% | n/m |
|---|
PACSPACS, Medical - Care Facilities | $7.2B | 26.0× | 1.3× | +15% | 4.8% | n/m |
|---|
MSAMSA Safety, Medical - Instruments & Supplies | $7.2B | 23.2× | 3.7× | +6% | 16.1% | n/m |
|---|
BLCOBausch & Lomb, Medical - Instruments & Supplies | $7.1B | n/m | 1.3× | +9% | −3.2% | n/m |
|---|
AXSMAxsome Therapeutics, Drug Manufacturers - General | $7.1B | n/m | 9.2× | +57% | −24.7% | n/m |
|---|
CHEChemed, Medical - Care Facilities | $7.1B | 27.2× | 2.7× | +3% | 10.6% | n/m |
|---|
KNSAKiniksa Pharmaceuticals International, Drug Manufacturers - General | $7.1B | 93.6× | 8.4× | +59% | 9.6% | n/m |
|---|
IONSIonis Pharmaceuticals, Drug Manufacturers - General | $6.9B | n/m | 7.8× | −7% | −64.7% | n/m |
|---|
LNTHLantheus, Medical - Diagnostics & Research | $6.5B | 24.3× | 4.2× | +2% | 17.7% | n/m |
|---|
AMRXAmneal Pharmaceuticals, Drug Manufacturers - General | $6.5B | 41.7× | 2.1× | +9% | 5.0% | n/m |
|---|
RYTMRhythm Pharmaceuticals, Drug Manufacturers - General | $6.4B | n/m | 26.8× | +54% | −85.6% | n/m |
|---|
ORKAOruka Therapeutics, Drug Manufacturers - General | $6.3B | n/m | n/m | n/m | n/m | n/m |
|---|
KODKodiak Sciences, Biotechnology | $6.1B | n/m | n/m | n/m | n/m | n/m |
|---|
LGNDLigand Pharmaceuticals, Drug Manufacturers - General | $6.1B | 32.7× | 21.1× | +55% | 67.9% | n/m |
|---|
GRALGRAIL, Medical - Diagnostics & Research | $6B | n/m | 36.2× | +23% | n/m | n/m |
|---|
TFXTeleflex, Medical - Instruments & Supplies | $6B | n/m | 2.6× | +31% | −45.8% | n/m |
|---|
HIMSHims & Hers Health, Medical - Care Facilities | $5.9B | n/m | 2.3× | +28% | −5.5% | n/m |
|---|
IMVTImmunovant, Biotechnologycaveat | $5.9B | n/m | n/m | n/m | n/m | n/m |
|---|
RDNTRadNet, Medical - Diagnostics & Research | $5.8B | n/m | 2.5× | +19% | −0.9% | n/m |
|---|
MIRMMirum Pharmaceuticals, Drug Manufacturers - General | $5.6B | n/m | 9.0× | +44% | n/m | n/m |
|---|
CGONCG Oncology, Biotechnology | $5.5B | n/m | n/m | n/m | n/m | n/m |
|---|
HAEHaemonetics, Medical - Instruments & Supplies | $5.5B | 58.9× | 4.0× | +0% | 7.1% | n/m |
|---|
MANEVeradermics, Drug Manufacturers - Generalcaveat | $5.4B | n/m | n/m | n/m | n/m | n/m |
|---|
MMEDMiniMed, Medical - Instruments & Suppliescaveat | $5.3B | n/m | n/m | n/m | n/m | n/m |
|---|
SRRKScholar Rock, Biotechnology | $5.2B | n/m | n/m | n/m | n/m | n/m |
|---|
BLLNBillionToOne, Medical - Diagnostics & Researchcaveat | $5.2B | 170× | 13.1× | +90% | 9.5% | n/m |
|---|
COGTCogent Biosciences, Drug Manufacturers - General | $5.2B | n/m | n/m | n/m | n/m | n/m |
|---|
CONConcentra Group Holdings Parent, Medical - Care Facilities | $5.1B | 26.2× | 2.2× | +14% | 8.7% | n/m |
|---|
PTCTPTC Therapeutics, Drug Manufacturers - General | $5.1B | n/m | 4.4× | −35% | −9.2% | n/m |
|---|
LFSTLifeStance Health, Medical - Care Facilities | $5.1B | 102× | 3.2× | +20% | 3.2% | n/m |
|---|
SHCSotera Health, Medical - Care Facilities | $5.1B | 31.1× | 4.2× | +8% | 13.4% | n/m |
|---|
MMSIMerit Medical Systems, Medical - Instruments & Supplies | $5.1B | 31.7× | 3.1× | +9% | 9.9% | n/m |
|---|
VNTVontier, Medical - Instruments & Supplies | $5B | 15.3× | 1.6× | +1% | 11.3% | n/m |
|---|
ERASErasca, Drug Manufacturers - General | $4.9B | n/m | n/m | n/m | n/m | n/m |
|---|
CRSPCRISPR Therapeutics, Biotechnology | $4.8B | n/m | n/m | −34% | n/m | n/m |
|---|
OPCHOption Care Health, Medical - Care Facilities | $4.7B | 23.8× | 0.8× | +6% | 3.7% | n/m |
|---|
HTFLHeartflow, Medical - Instruments & Supplies | $4.7B | n/m | 22.3× | +43% | −55.8% | n/m |
|---|
TVTXTravere Therapeutics, Drug Manufacturers - General | $4.6B | n/m | 7.9× | +49% | −7.4% | n/m |
|---|
DNTHDianthus Therapeutics, Drug Manufacturers - General | $4.6B | n/m | n/m | −61% | n/m | n/m |
|---|
CDNACareDx, Medical - Diagnostics & Researchcaveat | $4.5B | 35.9× | 9.1× | +39% | 25.9% | n/m |
|---|
BMIBadger Meter, Medical - Instruments & Supplies | $4.5B | 36.4× | 5.1× | −2% | 14.4% | n/m |
|---|
LIVNLivaNova, Medical - Devices | $4.4B | 23.7× | 3.0× | +12% | 12.8% | n/m |
|---|
ITGRInteger, Medical - Devices | $4.3B | 42.5× | 2.4× | −0% | 5.7% | n/m |
|---|
INDVIndivior Pharmaceuticals, Drug Manufacturers - General | $4.3B | 10.2× | 3.1× | +16% | 32.8% | n/m |
|---|
IRTCiRhythm, Medical - Instruments & Supplies | $4.2B | n/m | 5.0× | +26% | −1.7% | n/m |
|---|
EWTXEdgewise Therapeutics, Drug Manufacturers - General | $4.1B | n/m | n/m | n/m | n/m | n/m |
|---|
ICUIICU Medical, Medical - Instruments & Supplies | $4.1B | 138× | 1.9× | −9% | 1.4% | n/m |
|---|
ADPTAdaptive Biotechnologies, Biotechnology | $4B | n/m | 13.0× | +50% | −20.7% | n/m |
|---|
NVSTEnvista, Medical - Instruments & Supplies | $4B | 42.6× | 1.4× | +12% | 3.3% | n/m |
|---|
VCYTVeracyte, Medical - Diagnostics & Research | $3.9B | 35.0× | 7.0× | +17% | 20.4% | n/m |
|---|
ARQTArcutis Biotherapeutics, Drug Manufacturers - General | $3.9B | 142× | 8.5× | +76% | 6.1% | n/m |
|---|
RLAYRelay Therapeutics, Biotechnologycaveat | $3.8B | n/m | n/m | +24% | n/m | n/m |
|---|
PLSEPulse Biosciences, Medical - Instruments & Supplies | $3.8B | n/m | n/m | n/m | n/m | n/m |
|---|
LQDALiquidia, Drug Manufacturers - General | $3.7B | 30.1× | 8.3× | n/m | 30.7% | n/m |
|---|
TNGXTango Therapeutics, Drug Manufacturers - General | $3.7B | n/m | 68.2× | +121% | n/m | n/m |
|---|
XENEXenon Pharmaceuticals, Drug Manufacturers - General | $3.6B | n/m | n/a | −100% | n/a | n/m |
|---|
IOVAIovance Biotherapeutics, Biotechnologycaveat | $3.6B | n/m | 11.2× | +35% | −89.1% | n/m |
|---|
OGNOrganon, Drug Manufacturers - General | $3.6B | 18.2× | 0.6× | −3% | 3.5% | n/m |
|---|
ACADAcadia Pharmaceuticals, Drug Manufacturers - General | $3.5B | n/m | 3.1× | +12% | 33.4% | n/m |
|---|
VKTXViking Therapeutics, Drug Manufacturers - General | $3.4B | n/m | n/a | n/m | n/a | n/m |
|---|
ABCLAbCellera Biologics, Drug Manufacturers - General | $3.4B | n/m | 51.5× | +101% | n/m | n/m |
|---|
PBLSParabilis Medicines, Drug Manufacturers - Generalcaveat | $3.4B | n/m | n/m | n/m | n/m | n/m |
|---|
CELCCelcuity, Medical - Diagnostics & Research | $3.3B | n/m | n/m | n/m | n/m | n/m |
|---|
ELVNEnliven Therapeutics, Drug Manufacturers - General | $3.3B | n/m | n/m | n/m | n/m | n/m |
|---|
DYNDyne Therapeutics, Drug Manufacturers - General | $3.2B | n/m | n/m | n/m | n/m | n/m |
|---|
TARSTarsus Pharmaceuticals, Biotechnology | $3.2B | n/m | 5.3× | +105% | −7.7% | n/m |
|---|
NHCNational Healthcare, Medical - Care Facilities | $3.2B | 22.7× | 2.0× | +7% | 9.0% | n/m |
|---|
AMLXAmylyx Pharmaceuticals, Drug Manufacturers - Generalcaveat | $3.1B | n/m | n/m | n/m | n/m | n/m |
|---|
IDYAIDEAYA Biosciences, Drug Manufacturers - General | $3.1B | n/m | 13.0× | n/m | −74.8% | n/m |
|---|
ATRCAtriCure, Medical - Instruments & Supplies | $3B | 285× | 5.3× | +14% | 1.9% | n/m |
|---|
SGRYSurgery Partners, Medical - Care Facilities | $3B | n/m | 0.9× | +4% | −2.6% | n/m |
|---|
IRONDisc Medicine, Drug Manufacturers - General | $3B | n/m | n/m | n/m | n/m | n/m |
|---|
DNLIDenali Therapeutics, Biotechnologycaveat | $3B | n/m | n/m | n/m | n/m | n/m |
|---|
BHCBausch Health Companies, Drug Manufacturers - General | $3B | n/m | 0.3× | +11% | −7.6% | n/m |
|---|
AXGNAxogen, Medical - Devices | $3B | n/m | 11.2× | +24% | −12.0% | n/m |
|---|
WRBYWarby Parker, Medical - Instruments & Supplies | $2.9B | 341× | 3.2× | +11% | 0.8% | n/m |
|---|
VRDNViridian Therapeutics, Drug Manufacturers - General | $2.9B | n/m | 40.3× | n/m | n/m | n/m |
|---|
AVAHAveanna Healthcare, Medical - Care Facilities | $2.9B | 10.7× | 1.1× | +20% | 10.6% | n/m |
|---|
NRIXNurix Therapeutics, Drug Manufacturers - General | $2.8B | 11.1× | 4.0× | n/m | 42.0% | n/m |
|---|
ACHCAcadia Healthcare, Medical - Care Facilities | $2.8B | n/m | 0.8× | +4% | −33.4% | n/m |
|---|
PRVAPrivia Health, Medical - Care Facilities | $2.7B | 101× | 1.2× | +24% | 1.2% | n/m |
|---|
BEAMBeam Therapeutics, Biotechnology | $2.7B | n/m | 17.1× | +163% | −54.7% | n/m |
|---|
MBXMBX Biosciences, Drug Manufacturers - General | $2.6B | n/m | n/m | n/m | n/m | n/m |
|---|
NEOGNeogen, Medical - Diagnostics & Research | $2.6B | n/m | 2.9× | −0% | −6.3% | n/m |
|---|
GRDNGuardian Pharmacy Services, Medical - Pharmaceuticalscaveat | $2.5B | 38.8× | 1.7× | +10% | 4.5% | n/m |
|---|
BKDBrookdale Senior Living, Medical - Care Facilities | $2.5B | n/m | 0.8× | −4% | −4.5% | n/m |
|---|
ADMAAdma Biologics, Biotechnology | $2.5B | 15.8× | 4.8× | +8% | 33.0% | n/m |
|---|
ZLABZai Lab, Drug Manufacturers - General | $2.4B | n/m | 5.4× | +5% | −41.9% | n/m |
|---|
MDPediatrix Medical, Medical - Care Facilities | $2.4B | 16.7× | 1.2× | +2% | 7.7% | n/m |
|---|
PBHPrestige Consumer Healthcare, Drug Manufacturers - General | $2.4B | 13.9× | 2.1× | −1% | 15.6% | n/m |
|---|
ADUSAddus HomeCare, Medical - Care Facilities | $2.3B | 22.1× | 1.6× | +16% | 7.1% | n/m |
|---|
NAMSNewAmsterdam Pharma, Drug Manufacturers - General | $2.3B | n/m | n/m | −89% | n/m | n/m |
|---|
TMDXTransMedics, Medical - Devices | $2.3B | 17.4× | 3.5× | +26% | 22.7% | n/m |
|---|
BHVNBiohaven, Drug Manufacturers - General | $2.3B | n/m | n/m | n/m | n/m | n/m |
|---|
CLOVClover Health Investments, Medical - Healthcare Plans | $2.3B | n/m | 0.9× | +54% | −0.7% | n/m |
|---|
CLDXCelldex Therapeutics, Medical - Diagnostics & Research | $2.3B | n/m | n/m | −97% | n/m | n/m |
|---|
RCUSArcus Biosciences, Drug Manufacturers - General | $2.3B | n/m | 19.4× | −55% | n/m | n/m |
|---|
PGNYProgyny, Medical - Care Facilities | $2.3B | 32.0× | 1.7× | +6% | 6.0% | n/m |
|---|
IMNMImmunome, Drug Manufacturers - General | $2.2B | n/m | n/a | −100% | n/a | n/m |
|---|
HRMYHarmony Biosciences, Drug Manufacturers - Generalcaveat | $2.2B | 12.3× | 2.3× | +24% | 18.9% | n/m |
|---|
XNCRXencor, Drug Manufacturers - General | $2.2B | n/m | 21.0× | −29% | n/m | n/m |
|---|
UFPTUFP Technologies, Medical - Instruments & Supplies | $2.2B | 30.6× | 3.5× | +7% | 11.4% | n/m |
|---|
PRGOPERRIGO, Drug Manufacturers - General | $2.2B | n/m | 0.5× | −4% | −41.9% | n/m |
|---|
VERAVera Therapeutics, Drug Manufacturers - General | $2.2B | n/m | n/m | n/m | n/m | n/m |
|---|
AUPHAurinia Pharmaceuticals, Drug Manufacturers - General | $2.2B | n/m | 6.7× | +21% | 97.7% | n/m |
|---|
SUPNSupernus Pharmaceuticals, Drug Manufacturers - General | $2.1B | n/m | 2.4× | +27% | −5.1% | n/m |
|---|
PVLAPalvella Therapeutics, Drug Manufacturers - General | $2.1B | n/m | n/m | n/m | n/m | n/m |
|---|
BCRXBiocryst Pharmaceuticals, Biotechnology | $2.1B | n/m | 2.2× | +69% | −40.9% | n/m |
|---|
VCELVericel, Biotechnology | $2.1B | 88.1× | 6.8× | +23% | 7.9% | n/m |
|---|
ZYMEZymeworks, Drug Manufacturers - General | $2.1B | n/m | 55.4× | −70% | n/m | n/m |
|---|
RXRXRecursion Pharmaceuticals, Biotechnology | $2.1B | n/m | 37.4× | +56% | n/m | n/m |
|---|
SEPNSepterna, Drug Manufacturers - General | $2B | n/m | 20.4× | n/m | −24.5% | n/m |
|---|
ALMRAlamar Biosciences, Medical - Diagnostics & Researchcaveat | $2B | n/m | n/m | n/m | n/m | n/m |
|---|
XRAYDENTSPLY SIRONA, Medical - Instruments & Supplies | $2B | n/m | 0.5× | −1% | −15.0% | n/m |
|---|
SDGRSchrodinger, Drug Manufacturers - General | $2B | n/m | 7.6× | +9% | −21.0% | n/m |
|---|
INSPInspire Medical Systems, Medical - Instruments & Supplies | $1.9B | 14.5× | 2.2× | −0% | 15.0% | n/m |
|---|
TRVITrevi Therapeutics, Drug Manufacturers - General | $1.9B | n/m | n/m | n/m | n/m | n/m |
|---|
SRPTSarepta Therapeutics, Drug Manufacturers - Generalcaveat | $1.9B | n/m | 1.0× | −20% | −6.9% | n/m |
|---|
FTREFortrea, Medical - Diagnostics & Researchcaveat | $1.9B | n/m | 0.7× | −3% | −2.6% | n/m |
|---|
COAGHemab Therapeutics, Biotechnologycaveat | $1.9B | n/m | n/m | n/m | n/m | n/m |
|---|
WGSGeneDx, Medical - Care Facilities | $1.9B | n/m | 4.2× | +25% | −23.4% | n/m |
|---|
BRVEBraveheart Bio, Drug Manufacturers - Generalcaveat | $1.9B | n/m | n/m | n/m | n/m | n/m |
|---|
MRVIMaravai Lifesciences, Drug Manufacturers - General | $1.9B | n/m | 8.9× | −5% | −37.1% | n/m |
|---|
VIRVir Biotechnology, Biotechnology | $1.9B | n/m | 6.1× | n/m | −83.0% | n/m |
|---|
LMATLemaitre Vascular, Medical - Instruments & Supplies | $1.9B | 28.5× | 7.1× | +12% | 25.0% | n/m |
|---|
XERSXeris Biopharma, Drug Manufacturers - General | $1.9B | n/m | 5.5× | +36% | −5.1% | n/m |
|---|
REPLReplimune, Biotechnology | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
PGENPrecigen, Drug Manufacturers - Generalcaveat | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
ESTAEstablishment Labs, Medical - Instruments & Supplies | $1.8B | n/m | 7.4× | +39% | −15.8% | n/m |
|---|
ZBIOZenas BioPharma, Drug Manufacturers - Generalcaveat | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
AGIOAgios Pharmaceuticals, Drug Manufacturers - General | $1.8B | n/m | 18.2× | +141% | n/m | n/m |
|---|
KMTSKestra Medical Technologies, Medical - Instruments & Supplies | $1.8B | n/m | 16.6× | +61% | n/m | n/m |
|---|
HCSGHealthcare Services, Medical - Care Facilities | $1.7B | 17.3× | 0.9× | +4% | 5.6% | n/m |
|---|
SLSSELLAS Life Sciences, Drug Manufacturers - General | $1.7B | n/m | n/m | n/m | n/m | n/m |
|---|
STOKStoke Therapeutics, Drug Manufacturers - General | $1.7B | n/m | 61.9× | −86% | n/m | n/m |
|---|
GENBGenerate Biomedicines, Drug Manufacturers - Generalcaveat | $1.7B | n/m | n/m | n/m | n/m | n/m |
|---|
MAZEMaze Therapeutics, Biotechnologycaveat | $1.7B | n/m | n/m | n/m | n/m | n/m |
|---|
PSNLPersonalis, Medical - Diagnostics & Research | $1.7B | n/m | 24.2× | −13% | n/m | n/m |
|---|
URGNUroGen Pharma, Drug Manufacturers - General | $1.7B | n/m | 8.9× | +100% | −51.7% | n/m |
|---|
ABSIAbsci, Medical - Diagnostics & Research | $1.7B | n/m | n/m | −62% | n/m | n/m |
|---|
ARDTArdent Health, Medical - Care Facilities | $1.7B | 21.3× | 0.3× | +3% | 1.2% | n/m |
|---|
BFLYButterfly Network, Medical - Devices | $1.6B | n/m | 13.3× | +39% | −43.6% | n/m |
|---|
NTLAIntellia Therapeutics, Medical - Diagnostics & Research | $1.6B | n/m | 27.5× | +13% | n/m | n/m |
|---|
The largest 250 of 874.
Rankings of healthcare stocks
Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.